Logo 1 Logo 2

Clinical Trial Details

Trial ID: L7051
Source ID: NCT01447147
Associated Drug: Placebo
Title: A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic Nephropathy
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetic Nephropathy|Type 2 Diabetes Mellitus
Interventions: DRUG: Placebo|DRUG: CCX140-B|DRUG: CCX140-B
Outcome Measures: Primary: Subject incidence of adverse events, The primary objective of this study is to evaluate the safety and tolerability of CCX140-B in subjects with diabetic nephropathy., Up to 365 days | Secondary: Change from baseline in first morning urinary albumin:creatinine ratio (ACR), Up to 365 days
Sponsor/Collaborators: Sponsor: Amgen
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 332
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2011-10
Completion Date: 2014-12
Results First Posted:
Last Update Posted: 2025-02-27
Locations: Antwerp, Belgium|Brussels, Belgium|Edegem, Belgium|Ghent, Belgium|Leuven, Belgium|Liege, Belgium|Roeselare, Belgium|Beroun, Czechia|Brno, Czechia|Hlucin, Czechia|Neratovice, Czechia|Novy Jicin, Czechia|NZdar Nad Sazavou, Czechia|Pardubice, Czechia|Prague, Czechia|Prelouc, Czechia|Rakovnik, Czechia|Slany, Czechia|Trebic, Czechia|Uhersky Brod, Czechia|Unicov, Czechia|Berlin, Germany|Bosenheim, Germany|Deggingen, Germany|Dresden, Germany|Erlangen, Germany|Hannover, Germany|Heidelberg, Germany|Heilbronn, Germany|Hoyerswerda, Germany|Koeln, Germany|Munich, Germany|Neuwied, Germany|Nuernberg, Germany|Pirna, Germany|Potsdam, Germany|Saarlouis, Germany|Speyer, Germany|Wiesbaden, Germany|Baja, Hungary|Balatonfuered, Hungary|Bekescsaba, Hungary|Budapest, Hungary|Debrecen, Hungary|Eger, Hungary|Gyula, Hungary|Hatvan, Hungary|Kaposvar, Hungary|Kisvarda, Hungary|Satoraljaujhely, Hungary|Szekszard, Tolna, Hungary|Szikszo, Hungary|Bialystok, Poland|Ciechanow, Poland|Gdansk, Poland|Grodzisk Mazowiecki, Poland|Krakow, Poland|Poznan, Poland|Radom, Poland|Rzeszow, Poland|Szczecin, Poland|Warsaw, Poland|Wroclaw, Poland|Bath, United Kingdom|Belfast, United Kingdom|Birmingham, United Kingdom|Bristol, United Kingdom|Chester, United Kingdom|Coventry, United Kingdom|Doncaster, United Kingdom|Edmonton, United Kingdom|Liverpool, United Kingdom|Livingston, United Kingdom|Londonderry, United Kingdom|London, United Kingdom|Manchester, United Kingdom|Middlesbrough, United Kingdom|Norfolk, United Kingdom|Preston, United Kingdom|Salford, United Kingdom|Sheffield, United Kingdom|Swansea, United Kingdom|Welwyn Garden City, United Kingdom
URL: https://clinicaltrials.gov/show/NCT01447147

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress